Four Tyrosine Residues in Phospholipase C-γ2, Identified as Btk-dependent Phosphorylation Sites, Are Required for B Cell Antigen Receptor-coupled Calcium Signaling

Osaka University, Suika, Ōsaka, Japan
Journal of Biological Chemistry (Impact Factor: 4.6). 11/2001; 276(42):38595-601. DOI: 10.1074/jbc.M103675200
Source: PubMed

ABSTRACT Activation of phospholipase C-gamma2 (PLCgamma2) is the critical step in B cell antigen receptor (BCR)-coupled calcium signaling. Although genetic dissection experiments on B cells have demonstrated that Bruton's tyrosine kinase (Btk) and Syk are required for activating PLCgamma2, the exact activation mechanism of PLCgamma2 by these kinases has not been established. We identify the tyrosine residues 753, 759, 1197, and 1217 in rat PLCgamma2 as Btk-dependent phosphorylation sites by using an in vitro kinase assay. To evaluate the role of these tyrosine residues in phosphorylation-dependent activation of PLCgamma2, PLCgamma2-deficient DT40 cells were reconstituted with a series of mutant PLCgamma2s in which the phenylalanine was substituted for tyrosine. Substitution of all four tyrosine residues almost completely eliminated the BCR-induced PLCgamma2 phosphorylation, indicating that these residues include the major phosphorylation sites upon BCR engagement. Cells expressing PLCgamma2 with a single substitution exhibited some extent of reduction in calcium mobilization, whereas those expressing quadruple mutant PLCgamma2 showed greatly reduced calcium response. These findings indicate that the phosphorylations of the tyrosine residues 753, 759, 1197, and 1217, which have been identified as Btk-dependent phosphorylation sites in vitro, coordinately contribute to BCR-induced activation of PLCgamma2.

  • Source
    • "Wild-type human SOCS-1 and mutant SOCS-1 cDNA were amplified by polymerase chain reaction (PCR) from genomic DNA, inserted into the pApuro2 vector, and confirmed by DNA sequencing. DNA transfection into 293T cells with Lipofectamine (Invitrogen Corp., Carlsbad, CA, USA) has been described elsewhere (Watanabe et al, 2001). cDNAs of mouse wild-type SOCS-1 or R105Q mutant, which was introduced into the Arg-105 point mutation of SOCS-1 to yield Gln, were co-transfected with pSVIINeo as described previously (Narazaki et al, 1998) and selected in the presence of 500 lg/ml of G418 (Nakarai Tesque, "
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to investigate whether the suppressor of cytokine signalling (SOCS)-1 can act as a tumour suppressor when functioning as a negative regulator of the Janus family tyrosine kinases (JAKs), which have been reported to play important roles in leukaemogenesis. For this purpose, we carried out molecular analysis of the SOCS-1 gene in human acute myeloid leukaemia (AML) and human haematopoietic cell lines. Sequencing alterations in the coding region were found in two of 90 primary AML samples and one of 17 cell lines. Hypermethylation of the SOCS-1 gene was also observed in 72% of primary cases and 52% of cell lines and aberrant methylation strongly correlated with reduced expression. Transfection of SOCS-1 into Jurkat cells harbouring the mutation and methylation suppressed cell growth at a low serum concentration. These findings indicate that SOCS-1 is frequently silenced in haematopoietic malignancies, mainly as a result of hypermethylation, and suggest that SOCS-1 may be able to function as a tumour suppressor.
    British Journal of Haematology 10/2004; 126(5):726-35. DOI:10.1111/j.1365-2141.2004.05107.x · 4.96 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: One hurdle of long-term manned spaceflight is the reduction in cellular immunity experienced by astronauts in the microgravity environment. T lymphocytes, the primary effectors of cellular immunity, are unresponsive to mitogenic lectins or T cell receptor (TCR) ligation when cultured in vitro during spaceflight. Responsiveness can be partially rescued by directly activating the diacyl glycerol- (DAG) and calcium-signaling pathways that lie downstream of the TCR. Studies using rotating wall vessel (RWV) bioreactors as ground-based microgravity analogs have shown that sub-mitogenic doses of PMA, a DAG mimetic, can rescue T cell activation in response to mitogenic-lectins and -antibodies. Based on these findings we hypothesized that RWV-culture impairs T cell activation by affecting the generation of or response to the DAG second-messenger. This hypothesis was investigated by making comparative analyses of TCR-induced signal transduction in primary human CD4+ T cells in RWV- and 1-g (static)-culture. Our results show that TCR-induced phospholipase Cγ1 (PLCγ1) activation and the subsequent generation of DAG is unimpaired in CD4+ T lymphocytes cultured in the RWV. Furthermore, the primary targets of the DAG second-message, the guanylnucleotide replacing protein for RAS (RASGRP) and protein kinase cθ (PKCθ), were both activated by cells cultured in the RWV. Gene expression downstream of these enzymes, however, was only induced by T cells cultured in static conditions. A closer inspection of these pathways indicated that during culture in the RWV the extracellular regulated kinase (ERK), which is downstream of RASGRP, may become sequestered in the cytosol and thus prevented from mediating gene expression in the nucleus. Based on these results we conclude, that altered compartmentalization of ERK prevents T cells from becoming activated in the RWV by limiting the activation of key transcription factors required for the cell to become activated and enter the cell-cycle.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Das onkogene Epstein-Barr-Virus (EBV), der Erreger der infektiösen Mononukleose, gehört zur Gruppe der humanpathogenen [gamma]-Herpesviren. Durch Etablierung eines latenten Zustands, in dem keine infektiösen Viruspartikel gebildet werden, kann das Virus seiner vollständigen Eliminierung durch das Immunsystem entgehen und im Organismus persistieren. EBV etabliert die Latenz in einer Population ruhender B-Gedächtniszellen, aus denen es reaktiviert werden kann und den lytischen Zyklus initiieren kann. Das Latente Membranprotein (LMP) 2A von EBV ist der Lage, Signalleitungsprozesse in B-Zellen zu beeinflussen. Bisherige Untersuchungen der LMP2A-vermittelten Signalleitung stützen sich überwiegend auf in vitro mit EBV infizierte, sogenannte Lymphoblastoide Zelllinien (LCLs). In LCLs induziert die Expression von LMP2A die konstitutive Phosphorylierung BCR-proximaler Signalproteine und inhibiert gleichzeitig die BCR-abhängige Ca2+-Mobilisierung. Allerdings exprimieren LCLs weitere EBV-codierte Proteine, so dass sich die isolierte Funktion von LMP2A in diesem Zellsystem nicht eindeutig bestimmen lässt. Im Rahmen dieser Arbeit sollte die LMP2A-vermittelte Signalleitung in B-Lymphocyten in statu nascendi und unabhängig von weiteren viralen Proteinen untersucht werden. Dazu wurde ein Cre/loxP-basiertes Expressionssystem zur Analyse der LMP2A-Signalleitung in DT40 B-Lymphocyten verwendet, das es erlaubt, die Expression von LMP2A gezielt zu regulieren. Mit Hilfe dieses Systems konnte nachgewiesen werden, dass LMP2A ligandenunabhängig BCR-proximale Signalwege aktivieren kann. Die Aktivierung beschränkt sich dabei nicht wie in LCLs auf membrannahe Signalprozesse wie die Phosphorylierung der Signalproteine Lyn, Syk und SLP-65, sondern umfasst auch die Aktivierung von PLC-[gamma]2, einem Schlüsselenzym der cytosolischen Ca2+-Mobilisierung. Die Expression von LMP2A induziert Oszillationen der intrazellulären Ca2+-Konzentration, die zur Aktivierung der Transkriptionsfaktoren NFAT und NF-kB führen. Diese konstitutive Signalleitung durch LMP2A ist abhängig von der Membrantopologie des cytosolischen N-Terminus. Darüber hinaus konnte gezeigt werden, dass diese durch LMP2A vermittelten Signale die Aktivierung des EBV-Promotors pZ induzieren und so zur Initiation des lytischen Replikationszyklus von EBV beitragen können.
Show more